GLEPP1	glepp1	O	O
receptor	receptor	O	O
tyrosine	tyrosine	S_chemical	O
phosphatase	phosphatase	O	O
(	(	O	O
Ptpro	ptpro	O	O
)	)	O	O
in	in	O	O
rat	rat	O	O
PAN	pan	S_chemical	B_disease
nephrosis	nephrosis	O	S_disease
.	.	O	O

A	a	O	O
marker	marker	O	O
of	of	O	O
acute	acute	O	B_disease
podocyte	podocyte	O	B_disease
injury	injury	O	I_disease
.	.	O	O

Glomerular	glomerular	O	O
epithelial	epithelial	O	O
protein	protein	O	O
1	1	O	O
(	(	O	O
GLEPP1	glepp1	O	O
)	)	O	O
is	is	O	O
a	a	O	O
podocyte	podocyte	O	S_disease
receptor	receptor	O	O
membrane	membrane	O	O
protein	protein	O	O
tyrosine	tyrosine	S_chemical	O
phosphatase	phosphatase	O	O
located	located	O	O
on	on	O	O
the	the	O	O
apical	apical	O	O
cell	cell	O	O
membrane	membrane	O	O
of	of	O	O
visceral	visceral	O	O
glomerular	glomerular	O	O
epithelial	epithelial	O	O
cell	cell	O	O
and	and	O	O
foot	foot	O	O
processes	processes	O	O
.	.	O	O

This	this	O	O
receptor	receptor	O	O
plays	plays	O	O
a	a	O	O
role	role	O	O
in	in	O	O
regulating	regulating	O	O
the	the	O	O
structure	structure	O	O
and	and	O	O
function	function	O	O
of	of	O	O
podocyte	podocyte	O	S_disease
foot	foot	O	O
process	process	O	O
.	.	O	O

To	to	O	O
better	better	O	O
understand	understand	O	O
the	the	O	O
utility	utility	O	O
of	of	O	O
GLEPP1	glepp1	O	O
as	as	O	O
a	a	O	O
marker	marker	O	O
of	of	O	O
glomerular	glomerular	O	B_disease
injury	injury	O	I_disease
,	,	O	O
the	the	O	O
amount	amount	O	O
and	and	O	O
distribution	distribution	O	O
of	of	O	O
GLEPP1	glepp1	O	O
protein	protein	O	O
and	and	O	O
mRNA	mrna	O	O
were	were	O	O
examined	examined	O	O
by	by	O	O
immunohistochemistry	immunohistochemistry	O	O
,	,	O	O
Western	western	O	O
blot	blot	O	O
and	and	O	O
RNase	rnase	O	O
protection	protection	O	O
assay	assay	O	O
in	in	O	O
a	a	O	O
model	model	O	O
of	of	O	O
podocyte	podocyte	O	B_disease
injury	injury	O	I_disease
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

Puromycin	puromycin	B_chemical	O
aminonucleoside	aminonucleoside	S_chemical	O
nephrosis	nephrosis	O	S_disease
was	was	O	O
induced	induced	O	O
by	by	O	O
single	single	O	O
intraperitoneal	intraperitoneal	O	O
injection	injection	O	O
of	of	O	O
puromycin	puromycin	B_chemical	O
aminonucleoside	aminonucleoside	S_chemical	O
(	(	O	O
PAN	pan	S_chemical	O
,	,	O	O
20	20	O	O
mg/100	mg/100	O	O
g	g	O	O
BW	bw	O	O
)	)	O	O
.	.	O	O

Tissues	tissues	O	O
were	were	O	O
analyzed	analyzed	O	O
at	at	O	O
0	0	O	O
,	,	O	O
5	5	O	O
,	,	O	O
7	7	O	O
,	,	O	O
11	11	O	O
,	,	O	O
21	21	O	O
,	,	O	O
45	45	O	O
,	,	O	O
80	80	O	O
and	and	O	O
126	126	O	O
days	days	O	O
after	after	O	O
PAN	pan	S_chemical	O
injection	injection	O	O
so	so	O	O
as	as	O	O
to	to	O	O
include	include	O	O
both	both	O	O
the	the	O	O
acute	acute	O	B_disease
phase	phase	O	I_disease
of	of	O	O
proteinuria	proteinuria	O	S_disease
associated	associated	O	B_disease
with	with	O	I_disease
foot	foot	O	O
process	process	O	O
effacement	effacement	O	O
(	(	O	O
days	days	O	O
5	5	O	O
-	-	O	O
11	11	O	O
)	)	O	O
and	and	O	O
the	the	O	O
chronic	chronic	O	O
phase	phase	O	O
of	of	O	O
proteinuria	proteinuria	O	S_disease
associated	associated	O	B_disease
with	with	O	I_disease
glomerulosclerosis	glomerulosclerosis	O	S_disease
(	(	O	O
days	days	O	O
45	45	O	O
-	-	O	O
126	126	O	O
)	)	O	O
.	.	O	O

At	at	O	O
day	day	O	O
5	5	O	O
,	,	O	O
GLEPP1	glepp1	O	O
protein	protein	O	O
and	and	O	O
mRNA	mrna	O	O
were	were	O	O
reduced	reduced	O	O
from	from	O	O
the	the	O	O
normal	normal	O	O
range	range	O	O
(	(	O	O
265.2	265.2	O	O
+	+	O	O
/-	/-	O	O
79.6	79.6	O	O
x	x	O	O
10(6	10(6	O	O
)	)	O	O
moles/glomerulus	moles/glomerulus	O	O
and	and	O	O
100	100	O	O
%	%	O	O
)	)	O	O
to	to	O	O
15	15	O	O
%	%	O	O
of	of	O	O
normal	normal	O	O
(	(	O	O
41.8	41.8	O	O
+	+	O	O
/-	/-	O	O
4.8	4.8	O	O
x	x	O	O
10(6	10(6	O	O
)	)	O	O
moles/glomerulus	moles/glomerulus	O	O
,	,	O	O
p	p	O	O
<	<	O	O
0.005	0.005	O	O
)	)	O	O
.	.	O	O

This	this	O	O
occurred	occurred	O	O
in	in	O	O
association	association	O	O
with	with	O	O
an	an	O	O
increase	increase	O	O
in	in	O	O
urinary	urinary	O	O
protein	protein	O	O
content	content	O	O
from	from	O	O
1.8	1.8	O	O
+	+	O	O
/-	/-	O	O
1	1	O	O
to	to	O	O
99.0	99.0	O	O
+	+	O	O
/-	/-	O	O
61	61	O	O
mg/day	mg/day	O	O
(	(	O	O
p	p	O	O
<	<	O	O
0.001	0.001	O	O
)	)	O	O
.	.	O	O

In	in	O	O
contrast	contrast	O	O
,	,	O	O
podocalyxin	podocalyxin	S_chemical	O
did	did	O	O
not	not	O	O
change	change	O	O
significantly	significantly	O	O
at	at	O	O
this	this	O	O
time	time	O	O
.	.	O	O

By	by	O	O
day	day	O	O
11	11	O	O
,	,	O	O
GLEPP1	glepp1	O	O
protein	protein	O	O
and	and	O	O
mRNA	mrna	O	O
had	had	O	O
begun	begun	O	O
to	to	O	O
return	return	O	O
towards	towards	O	O
baseline	baseline	O	O
.	.	O	O

By	by	O	O
day	day	O	O
45	45	O	O
-	-	O	O
126	126	O	O
,	,	O	O
at	at	O	O
a	a	O	O
time	time	O	O
when	when	O	O
glomerular	glomerular	O	O
scarring	scarring	O	O
was	was	O	O
present	present	O	O
,	,	O	O
GLEPP1	glepp1	O	O
was	was	O	O
absent	absent	O	O
from	from	O	O
glomerulosclerotic	glomerulosclerotic	O	S_disease
areas	areas	O	O
although	although	O	O
the	the	O	O
total	total	O	O
glomerular	glomerular	O	O
content	content	O	O
of	of	O	O
GLEPP1	glepp1	O	O
was	was	O	O
not	not	O	O
different	different	O	O
from	from	O	O
normal	normal	O	O
.	.	O	O

We	we	O	O
conclude	conclude	O	O
that	that	O	O
GLEPP1	glepp1	O	O
expression	expression	O	O
,	,	O	O
unlike	unlike	O	O
podocalyxin	podocalyxin	S_chemical	O
,	,	O	O
reflects	reflects	O	O
podocyte	podocyte	O	B_disease
injury	injury	O	I_disease
induced	induced	O	O
by	by	O	O
PAN	pan	S_chemical	O
.	.	O	O

GLEPP1	glepp1	O	O
expression	expression	O	O
may	may	O	O
be	be	O	O
a	a	O	O
useful	useful	O	O
marker	marker	O	O
of	of	O	O
podocyte	podocyte	O	B_disease
injury	injury	O	I_disease
.	.	O	O

